Seattle Genetics Win Early US FDA Approval For Tukysa, Plans Rapid Launch

FDA Approved typed words on a vintage typewriter
Tukysa was approved for second-line or later HER2-positive breast cancer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip